Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Best D-Mannose Supplements with Cranberry in 2026: Buyer's Guide and Analysis
Healthcare & PharmaceuticalAdvertorial

Best D-Mannose Supplements with Cranberry in 2026: Buyer's Guide and Analysis

February 12, 2026 2:40 PM

What Is a D-Mannose supplement with cranberry D-Mannose supplements with cranberry have become a familiar product category for many people by 2026, yet they are still often misunderstood. For some buyers, these supplements are associated only with cranberry juice or occasional use, while others see them as part of a more structured daily wellness routine. Understanding what these supplements are, how they are typically used, and why certain...

Read more
Best NAC Antioxidant Supplements Are Identified in 2026: Research and Evaluation
Healthcare & PharmaceuticalAdvertorial

Best NAC Antioxidant Supplements Are Identified in 2026: Research and Evaluation

February 12, 2026 1:05 PM

How Consumers Evaluate NAC Supplement Quality - Purity, Dosage, and Practical Use As NAC supplements became more widely available, consumer evaluation standards also became stricter. By 2026, buyers no longer rely on generic labels such as "high potency" or "advanced antioxidant support." Instead, they apply a clear and repeatable set of criteria that focuses on purity, transparency, and real-life usability. This section explains how informed...

Read more
Dr. Patrick F. Doherty Recognized for Three Decades of Leadership in Advanced Neurosurgery and Patient Centered Care in Connecticut
Healthcare & PharmaceuticalCompany Update

Dr. Patrick F. Doherty Recognized for Three Decades of Leadership in Advanced Neurosurgery and Patient Centered Care in Connecticut

February 12, 2026 1:00 PM

Clinical Leadership in Neurosurgery and Spine Care Dr. Patrick F. Doherty, MD, a board-certified neurosurgeon with more than 30 years of clinical and academic experience, continues to be recognized as a leading authority in neurosurgery and advanced spine care in Connecticut. Based in New London, Dr. Doherty serves as Chief of Neurosurgery at Lawrence + Memorial Hospital and leads the hospital's Spine Care Center of Excellence. He also holds the...

Read more
ProstaVive Reviews (DOCTOR WARNING UPDATE 2026) Hidden Complaints, Ingredient Truth, and Safety Risks Men Need to Know
Healthcare & PharmaceuticalAdvertorial

ProstaVive Reviews (DOCTOR WARNING UPDATE 2026) Hidden Complaints, Ingredient Truth, and Safety Risks Men Need to Know

February 12, 2026 11:50 AM

As men cross into their 40s and 50s, the persistent interruptions of nighttime trips to the bathroom and the frustration of weakened urinary flow become far too common. With the aging prostate affecting millions of men, the launch of the supplement ProstaVive Powder arrives at a critical moment, offering a plant-based approach to prostate wellness that claims to bypass pharmaceuticals and their side-effects. But before you commit to this...

Read more
Black Book Research Publishes
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Publishes "Mexico Acute Care EHR and Digital Health 2026" in State of Global Healthcare IT & EHR Series

February 12, 2026 11:15 AM

Black Book Research today announced the publication of Mexico Acute Care EHR and Digital Health 2026, the newest country installment in its State of Global Healthcare IT and EHR Series 2026. The report delivers an independent, Mexico-specific market and policy analysis designed to help acute-care hospital leaders, digital health executives, informatics teams, and vendors make faster, better-informed decisions in a complex and rapidly evolving...

Read more
What Defines the Best GABA Supplements in 2026? Evaluation Criteria
Healthcare & PharmaceuticalAdvertorial

What Defines the Best GABA Supplements in 2026? Evaluation Criteria

February 12, 2026 10:40 AM

What GABA Supplements Are and Why People Use Them in 2026 By 2026, GABA supplements are no longer perceived as niche products used only during periods of acute stress. They have become part of everyday wellness routines for people who want to feel calmer, more balanced, and less overwhelmed by constant mental pressure. This shift reflects broader changes in lifestyle, work patterns, and how consumers think about long-term mental well-being. To...

Read more
Onco-Innovations Announces Amendment to Private Placement Pricing
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Announces Amendment to Private Placement Pricing

February 12, 2026 9:00 AM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it has amended the pricing of its previously-announced (see news release dated January 23, 2026) non-brokered private placement (the "Amended Private Placement"). Under the Amended Private Placement, the Company intends to issue up to 3,076,9233 units (each, a "Unit'') at a price of $0.65 per Unit, for aggregate gross...

Read more
ZetrOZ Systems Brings Wearable Ultrasound Technology to Pro Baseball's Spring Training
Healthcare & PharmaceuticalCompany Update

ZetrOZ Systems Brings Wearable Ultrasound Technology to Pro Baseball's Spring Training

February 12, 2026 9:00 AM

As pitchers and catchers report next week to baseball's spring training camps, ZetrOZ Systems will also be there, meeting with teams to present its sustained acoustic medicine (sam®) technology. The company's sam® wearable ultrasound device is proven effective in helping athletes recover from workouts, avoid health issues and recover more quickly from common soft-tissue injuries. ZetrOZ Systems has previously worked with the Professional...

Read more
AGFA HealthCare Accelerates U.S. Growth with Strategic Enterprise Imaging Wins
Healthcare & PharmaceuticalCompany Update

AGFA HealthCare Accelerates U.S. Growth with Strategic Enterprise Imaging Wins

February 12, 2026 8:30 AM

AGFA HealthCare continued its strong business momentum across the U.S. market, as health systems expand their use of scalable, cloud-based Enterprise Imaging solutions that support clinical efficiency, clinical collaboration, and organizational growth. A key highlight of this momentum is a new agreement with a rapidly growing, multi-state radiology group - delivering diagnostic imaging and professional reading services across 11 sites in four...

Read more
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Healthcare & PharmaceuticalCompany Update

MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

February 12, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for Orphan Drug Designation (ODD) for "NV-387 as a Treatment for MPox" with the US FDA Office of Orphan Products Development (OOPD). If approved,...

Read more
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))
Healthcare & PharmaceuticalCompany Update

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

February 12, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO). The application, titled "A Sublingual Powder Formulation of Ondansetron and Methods of Use Thereof," marks the first-ever sublingual powder delivery system...

Read more
Medicus Pharma on Bloomberg World
Healthcare & PharmaceuticalCompany Update

Medicus Pharma on Bloomberg World

February 12, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Matt Miller from Bloomberg World for a live interview on February 10, 2026. https://youtu.be/2-naOb7uJRc?si=eumsbejKNkAdQ62G In this live interview on Bloomberg World, Dr. Raza Bokhari, Executive...

Read more
Best Thyroid Support Supplements in 2026. Consumer Guide and Analysis
Healthcare & PharmaceuticalAdvertorial

Best Thyroid Support Supplements in 2026. Consumer Guide and Analysis

February 12, 2026 7:20 AM

What Thyroid Support Supplements Are and Why People Use Them in 2026 By 2026, thyroid support supplements are no longer a narrow or misunderstood category. They have become part of a broader discussion around nutritional balance, daily consistency, and long-term wellness routines. As consumer awareness has increased, so has the demand for supplements that are clearly explained, responsibly formulated, and easy to integrate into everyday life....

Read more
DNDi and Dubai Health Sign a Partnership to Advance Research and Training in Neglected Diseases
Healthcare & PharmaceuticalCompany Update

DNDi and Dubai Health Sign a Partnership to Advance Research and Training in Neglected Diseases

February 12, 2026 4:30 AM

Dubai Health has signed a Memorandum of Understanding (MoU) with the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) at World Health Expo Dubai (WHX). The agreement was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences, and Dr. Luis Pizarro, Executive Director of the Drugs for Neglected...

Read more
Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study

February 12, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European-based biotechnology company focused on the development of gene therapies for age-related diseases, announces positive preliminary interim results from its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial evaluating its proprietary SIRT6 centenarian gene therapy in aged dogs. Trial overview The randomised, blinded study, conducted by an...

Read more
FuturHealth Weight Loss in 2026: Is the Full GLP-1 Program With Nutrition and Meal Plans Worth It Beyond Just Medication?
Healthcare & PharmaceuticalAdvertorial

FuturHealth Weight Loss in 2026: Is the Full GLP-1 Program With Nutrition and Meal Plans Worth It Beyond Just Medication?

February 11, 2026 7:45 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription treatments that require evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any prescription weight loss program. Affiliate Disclosure: This article contains affiliate links. If a purchase is made through links in this article, a commission may be...

Read more
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
Healthcare & PharmaceuticalEarnings

Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025

February 11, 2026 4:30 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025. Revenue for the quarter ended December 31, 2025 was $11.3 million compared to $12.6 million for the quarter ended December 31, 2024, a decrease of $1.3 million or 10.3%. The Company had an operating loss of $0.9 million in the quarter ended December 31, 2025 compared to operating income in the quarter ended...

Read more
Abound Health Acquires Pro Care Unlimited, Expanding Its Mission and Services into Michigan
Healthcare & PharmaceuticalMergers and Acquisitions

Abound Health Acquires Pro Care Unlimited, Expanding Its Mission and Services into Michigan

February 11, 2026 2:40 PM

In a move that marks a significant milestone in its continued growth, Abound Health is proud to announce its acquisition of Pro Care Unlimited, a trusted provider of personal care and community living supports in Michigan. Effective January 1, 2026, Pro Care Unlimited officially joined the Abound Health family, bringing together two organizations with shared values and a commitment to high-quality, person-centered care. Founded more than 20...

Read more
Rythmia Life Advancement Center Surpasses $1 Million in Scholarship Awards, Sending 156 Recipients to Medically Licensed Ayahuasca Retreat
Healthcare & PharmaceuticalCompany Update

Rythmia Life Advancement Center Surpasses $1 Million in Scholarship Awards, Sending 156 Recipients to Medically Licensed Ayahuasca Retreat

February 11, 2026 1:50 PM

Rythmia Life Advancement Center, the world's only medically licensed plant medicine center, which recently celebrated 10 years in business, today announced that its Scholarship Program has awarded more than $1,008,105 in full retreat scholarships to 156 recipients - a milestone that underscores the center's commitment to making transformative plant medicine experiences accessible regardless of economic background. The Rythmia Scholarship Program...

Read more
New Analysis Finds Global Drug Pricing Benchmarking May Fall Short on Affordability
Healthcare & PharmaceuticalProduct Announcements

New Analysis Finds Global Drug Pricing Benchmarking May Fall Short on Affordability

February 11, 2026 1:30 PM

A new report by Aimed Alliance, international patient advocates, and advocacy organizations, found that due to the United States' unique health care system, an international reference pricing program, such as those proposed under the Centers for Medicare and Medicaid Services (CMS) GUARD and GLOBE models, may not meaningfully improve affordability for consumers. Aimed Alliance's new analysis, International Reference Pricing: Lessons Learned from...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?